The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 1,601–1,700 of 1,810
Meccariello, L. (2022) · Physician Assistant Clinics · doi:10.1016/j.cpha.2022.02.009
Association of prior COVID-19 infection with gestational diabetes mellitus
Sajnani, J., Siavoshi, M. A., Kwan, L., & Han, C. S. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113144 · Cited by 1
Ahishakiye, E. (2025) · Research Square · doi:10.21203/rs.3.rs-8277133/v1
Lazarou, E., Metallinou, D., Kolokotroni, O., Lambrinou, E., Miltiadous, P., Papaetis, G. S., Evripidou, A., Mikellidis, K. C., Kontos, C., Chrysostomou, S., et al. (2026) · Healthcare · doi:10.3390/healthcare14121791
do Nascimento, R. T. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.100.2022.tde-05092022-101003
Avocefohoun, A. S., Akpona, R. L. O., Montcho, P. S., et al. (2026) · Open Journal of Biophysics · doi:10.4236/ojbiphy.2026.164006
Salsabila, A. U., Suryadinata, R. V., Askitosari, T. D., et al. (2022) · Jurnal kesehatan komunitas (Journal of community health) · doi:10.25311/keskom.vol8.iss3.842
“Pada masa kehamilan, perempuan juga berisiko untuk terkena diabetes melitus gestasional yang semakin meningkatkan risiko untuk terkena diabetes melitus.(19) Pada kelompok diabetes, jumlah terbanyak adalah responden dengan usia >46 tahun.”
BackgroundBur, R., Danukusumo, D., Putra, M. A. R., Talib, S. R., Pramuktini, S., Safanta, N., Gebrina, M., Dewi, F. E. S., Dharmala, A. B., & Megawulandari, D. (2026) · Acta Medica Bulgarica · doi:10.2478/amb-2026-0041
Rauf, F., Ahmed, S. M. Y., Mehreen, M., Gilani, S. A., Jelany, S., Gilani, H. S. A., Umair, A., & Malik, M. (2025) · Italian Journal of Gynaecology and Obstetrics · doi:10.36129/jog.2025.202
“…fetus's normal growth mostly depends on the placenta's normal function, structure, and morphology. f A new estimate from the International Diabetes Foundation suggests that by the year of 2030, almost 438 million people worldwide or more than 4.5% worlds estimated population may have diabetes [1].”
InfluentialElectrochemical aptasensors for monitoring diabetes biomarkers
Shahdost-fard, F., & Jalal, N. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13633-7.00004-1
Andersson-Hall, U. K., Kristiansson, E., Åberg, S., Törnqvist, M., Wallenius, K., Sengpiel, V., & Holmäng, A. B. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/7103883
“This is consistent with current models of GDM pathophysiology and postpartum progression [16, 28, 29].”
Sharaby, S. A., Mohamed, H. H., & Fatthy, A. (2023) · Egyptian Journal of Health Care · doi:10.21608/ejhc.2023.335725
Diabetes mellitus como factor de riesgo para estenosis valvular aórtica
Vergara, D. M. C., & Torres, J. M. T. (2022) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v6i6.3809
Oguzhanoglu, M. K., & Oguzhanoglu, K. (2026) · Farabi Tıp Dergisi · doi:10.59518/farabimedj.1989077
Wang, Y., Junfeng, L. I., Wang, Y., & Guo, Y. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s545706
Diagnostic value of a logistic model of occupational lead poisoning using hematological parameters
Sun, G., Xiang, P., Chen, Y., et al. (2023) · Journal of International Medical Research · doi:10.1177/03000605231213221
Abdi, F., Rahnemaei, F. A., Khosravani, F., Sadri, F., & Mohammadi, Y. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/9942007
Silva, U. H. D., Dissanayake, M., & Amarasiri, S. S. (2023) · Journal of the Ceylon College of Physicians · doi:10.4038/jccp.v54i2.8010
Diané, A., Mu-u-min, R., & Al-Siddiqi, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146424
“…to GDM, insulin production, which inadequately compensates for the insulin-inhibiting effect proposed to be driven by the high levels of placental hormones (e.g., estrogen, and hPL) during mid-gestation, is impaired due to pancreatic β -cell dysfunction [6,45], thereby contributing to GDM [46].”
Gestasyonel Diyabeti Olan ve Olmayan Gebelerin Sosyal Jetlag ve Beslenme Durumunun İncelenmesi
Çatar, D., & Bayram, S. (2024) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.1309909
Skarstad, H. M. S., Haganes, K. L., Sujan, M. A. J., Gellein, T. M., Johansen, M., Salvesen, K. Å., Hawley, J. A., & Moholdt, T. T. (2024) · medRxiv · doi:10.1101/2024.05.06.24306931
Risk Factors For Occurring Preeclampsia In Pregnant Women : Literature Review
Desriva, N., Sansuwito, T. B., & Dioso, R. I. (2024) · International Journal of Health Sciences · doi:10.59585/ijhs.v2i1.314
“Behind that, the actual cause of preeclampsia is still a mystery (Plows et al., 2018).”
BackgroundFreire-Agulleiro, Ó., Lee, T. H.-Y., & Quarta, C. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10029-6
“In severe cases, it may contribute to neonatal encephalopathy, associated with an increased risk of corticospinal tract injury and adverse motor and cognitive outcomes [ 67–69].”
Liu, W., Hu, X., Huang, H., & He, M. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10789-3
“Gestational diabetes mellitus (GDM), one of the major barriers to improving maternal and infant health, is a transient diabetes mellitus caused by pancreatic β-cell dysfunction and gestational insulin resistance (Plows et al. 2018).”
Evaluation of Type 2 Diabetes Like Subtypes in Gestational DiabetesPreprint
Srour, L., Al‐Thani, N. M., Fthenou, E., Albagha, O., & Hajj, N. E. (2026) · medRxiv · doi:10.64898/2026.07.29.26359198
Alfaifi, M. A., Mansour, A., Yadav, B., & Khan, I. A. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s510344 · Cited by 1
“11,12 Furthermore, GDM is believed to be equivalent to T2DM in terms of pathogenic mechanism, including insulin resistance and β-cell dysfunction.”
Ye, Y., Xiao, X., Zhou, Q., & Li, X. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07844-1 · Cited by 1
“Selection of the covariates included in the models was based on findings in previous scientific literatures [18–20] and variates of region distribution, maternal age, maternal body mass index (BMI), gestational diabetes or pregestational diabetes and family history of hypertension or diabetes were…”
Liu, K., Gu, Y., Pan, X., Chen, S., Cheng, J., Zhang, L., & Cao, M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4806433
circVEGFC strengthens high glucose-induced trophoblast cell inflammation and apoptosis
Miao, F., & Wang, C. (2026) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2026.104851
Plant-based Diets and Diabetes
Slywitch, E. (2026) · Royal Society of Chemistry eBooks · doi:10.1039/9781837678907-00310 · Cited by 1
Maternal DNA Methylation Signatures of Gestational Diabetes across all Stages of PregnancyPreprint
Srour, L., Bejaoui, Y., Jerobin, J., et al. (2025) · medRxiv · doi:10.1101/2025.05.25.25328297
Sharma, A. K., Mahadule, A. A., Mittal, S., Mohan, L., Mirza, A. A., Bahadur, A., & Mittal, G. (2026) · Annals of Neurosciences · doi:10.1177/09727531261435737
Association of body mass index and perinatal outcomes of women delivering at advanced maternal age
Yan, G., Dong, Y., Yu, X., Zhang, L., Zhao, X., Zhou, J., Du, Y., & Wang, L. (2024) · Traditional Medicine and Modern Medicine · doi:10.1142/s2575900024500071
Alejandra, M.-H., Ricardo, E.-T., & Donjuán-Loredo, G. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1519410 · Cited by 1
Prediction of Diabetes in Middle-Aged Adults: A Machine Learning Approach
(2023) · doi:10.1101/2023.11.26.23299025
“Additionally, infants born to mothers with GD may experience macrosomia (excessive birth weight) and complications during birth [13].”
BackgroundWali, A., Akram, S., & Asaad, M. (2024) · Journal of The Pakistan Dental Association · doi:10.25301/jpda.324.130
PRINCIPAIS FATORES ASSOCIADOS A OCORRÊNCIA DE DIABETES GESTACIONAL: Uma revisão integrativa
de Moraes, L. G., de Oliveira, L. C. B., Tavares, W. J. G., & da Costa, R. S. L. (2026) · Scientia Generalis · doi:10.22289/sg.v7n1a40
Liu, W., Liu, R., Wu, Z., & Zhang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1763798 · Cited by 2
Druzhinina, A. A., Gyulakhmedova, S. M., Alyautdina, O. S., Bashokouh, F., Eliseeva, E. M., & Chistokhina, A. A. (2026) · Avicenna Bulletin · doi:10.25005/2074-0581-2026-28-1-122-139
“Врачу и пациентке следует учи - тывать неопределённость результатов и индивидуальные пред - почтения при совместном принятии решения об использовании инозитолов в качестве терапии СПЯ [31, 55].”
Blood-based indicators for pregnancy disorders: Advanced biophysical approaches
Koynova-Tenchovа, R., Krumova, S., Alexandrova, A., Tiankov, T., Abadjieva, E., Strijkova, V., Pencheva, T., & Todinova, S. J. (2026) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2026.07.007
Sousi, S., Greenfield, G., Hayhoe, B. W. J., Singh, N., Majeed, A., Darzi, A. W., & Neves, A. L. (2026) · Systematic Reviews · doi:10.1186/s13643-026-03244-4 · Cited by 1
“Key risk factors for GDM include advanced maternal age, elevated body mass index (BMI), certain ethnic backgrounds, a history of macrosomic birth (i.e. birth weight > 4 kg), prior GDM, and a family history of diabetes [2, 3].”
Vaithinathan, P., Alex Roy, X., Vaithiyanathan, S., Ganesan, C., & Mattyvanan, S. (2026) · Cureus · doi:10.7759/cureus.104800
“Regional genetic diversity, dietary factors, and variability in healthcare access may influence the relationship between Hp genotype and complication risk [13].”
MICRONUTRIENTES NA SÍNDROME PRÉ-MENSTRUAL: UMA REVISÃO INTEGRATIVA
de Oliveira, M. E. G., Ribeiro, R. R. A., & Veiga, D. K. E. (2023) · doi:10.56161/sci.ed.20230900c4
Yang, J., Qu, Y., Zhan, Y., Li, X., Man, D., Wu, H., Huang, P., Jiang, Y., & Ma, H. (2024) · Research Square · doi:10.21203/rs.3.rs-5428133/v1
Karakaya, H., Akarsu, G. D., Onat, T., & Akarsu, R. H. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15155977
“Because of this complexity, the exact cause of GDM remains unclear [18,19].”
Beernink, R. H. J., & Schuitemaker, J. H. N. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_33-1
Yin, Y., Wang, F., & Gong, H. (2026) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s566504
The association of diet quality scores with the adverse pregnancy outcomesPreprint
He, J., Li, Y., Chi, Y., Meng, Y., Mo, Y., Chen, C., & Qu, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3241312/v1
Chen, X., Yang, H., Zhao, A., Chen, X., Ji, R., Niu, Y., Wang, Y., & Ding, H. (2026) · Cells and Development · doi:10.1016/j.cdev.2026.204084
Yang, K., Zhai, P., Zhang, M., & Zhou, W. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119635
Robledo-Clemente, M. G., Godínez, J. C. S., Díaz-Velázquez, M. F., Mendoza-Reyes, E., Gómez-Archila, J. D., Montes, L. D. G., Chávez, M. R. C., Peña-Cano, M. I., & Saucedo, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178367
“GDM arises from a progressive increase in maternal insulin resistance coupled with insufficient pancreatic β -cell compensation, culminating in hyperglycemia [2].”
Fletcher, I., Walker, K. F., Poole, G., Mistry, K., Patel, N., & Mitchell, E. (2026) · Research Square · doi:10.21203/rs.3.rs-9924152/v1
Ginecologia e Obstetrícia - Edição XV
FREITAS, G. B. L. D., LIMA, G. M., & MENDES, J. C. C. (2024) · doi:10.59290/978-65-6029-188-1 · Cited by 1
Role of HbA1c in Prediction of Gestational Diabetes Mellitus Patients
Kardeşler, S., Topçu, D. İ., Terzioğlu, M. E., Kasap, E., & Çolak, A. (2024) · Forbes Journal of Medicine · doi:10.4274/forbes.galenos.2023.26023
Lazaridi, A., Raptis, A. E., Zarogiannis, S. G., Toska, A. G., Saridi, M. I., Fradelos, E., & Papagiannis, D. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-03402-1_19
Helm, M. M., Buccini, G., Schilling, B. K., Lindsay, A. R., & Basu, A. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2667410
“GDM has a similar pathophysiology to T2DM; however, the β-cell dysfunction is exacerbated due to increased glucose metabolism demands from the pregnancy (Plows et al. 2018).”
Ginecologia e Obstetrícia - Edição XII
FREITAS, G. B. L. D., & Chaves, J. H. B. (2024) · doi:10.59290/978-65-6029-138-6
Postprandial Hyperglycaemia Screening and Pregnancy Outcomes‐Lessons From COVID ‐19
Bastian, B., Smithers, L. G., Kunjunju, A., Pape, A., & François, M. E. (2025) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.70014 · Cited by 1
Intestinal Microbiota Modulation for Type 1 and Type 2 Diabetes Prevention
Kushwaha, K. K., Sharma, R., Subramani, S. K., & Raghuwanshi, S. (2022) · Springer eBooks · doi:10.1007/978-981-16-8444-9_5
Talmy, T., Cukierman‐Yaffe, T., Mazaki‐Tovi, S., Derazne, E., Tzur, D., Afek, A., Shina, A., Chodick, G., Twig, G., & Yoeli‐Ullman, R. (2026) · PLoS ONE · doi:10.1371/journal.pone.0351780
“…traits affecting both cognitive function and the underlying pathophysiology of GDM. Factors such as leptin, which is secreted by the placenta during pregnancy with increased production in GDM, [38] and is thought to play a role in cognition [49], may be involved in the underlying mechanism.”
Ribeiro, T. D. C., Rodrigues, R. D., Vitorino, A. L. D. S., da Silva, A. G., Chaves, M. M. G., de Freitas, G. L., & Moreira, A. D. (2026) · Revista gaúcha de enfermagem · doi:10.1590/1983-1447.2026.20250179.en
Piao, Y., & Jin, M. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261431025
“34 In addition, the function of pancreatic beta cells is often hindered, preventing the secretion of sufficient insulin to offset the resistance, which results in elevated blood glucose levels.”
Fan, G., Liu, Q., Zhang, L., Peng, J., Wu, L., Fang, Q., Guo, W., Liu, B., Yan, L., Li, J., et al. (2026) · Environmental Research · doi:10.1016/j.envres.2026.123836
Lu, S., Wang, J., Kakongoma, N., Hua, W., Xu, J., Wang, Y., He, S., Gu, H., Shi, J., & Hu, W. (2022) · Figshare · doi:10.6084/m9.figshare.19860260
Pereira, F. A. D. O., & Marvulo, M. F. V. (2023) · Seven International Medical and Nursing Congress · doi:10.56238/iicongressmedicalnursing-105
Polygenic Risk Score Associated with Gestational Diabetes Mellitus in an AmericanIndian Population
Peterson, K., Powe, C. E., Sun, Q., Azure, C., Azure, T., Davis, H., Gourneau, K., LaRocque, S., Poitra, C., Poitra, S., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15090395
“Risk factors such as maternal age, diet, increased body mass index (BMI), and family history have demonstrated strong association with GDM but no clear pathophysiology has been ascertained [6].”
Ruiz-García, M., Martínez‐García, I., Herreros-Solano, A., Patiño‐Cardona, S., Moreno-Charco, E., Martínez-Cabrera, L., González-Sánchez, A., & Pascual‐Morena, C. (2026) · Women · doi:10.3390/women6020031 · Cited by 1
Inflammation in Pregnant Women with Obesity and Gestational Diabetes Mellitus
Kim, T. S. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-39721-9_9 · Cited by 1
shallal, F., Sami, S., & Sameer, N. G. (2025) · Journal of Clinical Obstetrics and Gynecology Research · doi:10.52338/jocogr.2025.4606
Khatun, M. F., Akter, K., Kauser, U. S., Bagche, S., Rupa, M. G., Yasmin, A., & Alam, S. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20263418
Ersan, F., Alpay, V., Bilirer, K. K., Boza, B., & Erenel, H. (2026) · Journal of Medicine and Palliative Care · doi:10.47582/jompac.1873615
Zareei, S., Behrasi, F., Naghizadeh, M. M., Talebzadeh, F., Kharmandar, A., Farjam, M., & Homayounfar, R. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02528-4
“At least four pregnancies during reproductive ages may be a potential risk factor for diabetes in menopausal women without a history of gestational diabetes [46].”
BackgroundKusumawati, P. D., Komariyah, S., & Khomsiyatin, B. R. (2025) · Journal of Community Service for Health · doi:10.26699/jcsh.v6i1.1198
Николаевна, С. О., & Putilova, N. V. (2024) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2024-31-1-64-73
Circulating neutrophil extracellular traps and deoxyribonuclease in gestational diabetes mellitus
Sundet, B. K., Fiskå, B. S., Staff, A. C., Jacobsen, D., Bratseth, V., Palmero, S., Kindberg, K. M., Helseth, R., Lekva, T., Ueland, T., et al. (2026) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2026.104928 · Cited by 1
Mojsak, P., Godlewski, A., Sołowiej, K., Kulczynska–Przybik, A., Chmielewska, S., Mroczko, B., Szelachowska, M., Kretowski, A. J., & Ciborowski, M. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1760710
Megha, C. N., Kumar, K. K., & Moorthy, K. G. S. (2026) · Telangana Journal of Psychiatry · doi:10.4103/tjp.tjp_20_26
Janssen, S. M. W., Bouzembrak, Y., Cuypers, M., Tekinerdogan, B., & Leusink, G. (2026) · Frontiers in Endocrinology · doi:10.2196/preprints.89370
Pharmacological Evaluation of Tricholepis glaberrima for Antidiabetic potential in animal model
Chavan, K. R., Mohale, D., & Chandewar, A. V. (2024) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2024.00049
Moholdt, T. T., Haganes, K. L., Sujan, M. A. J., Gellein, T. M., Johansen, M. K., Salvesen, K. Å., Hawley, J. A., & Skarstad, H. M. S. (2024) · Research Square · doi:10.21203/rs.3.rs-4240857/v1
Lumbanraja, S. N., Aldiansyah, D., Lubis, M. P., Barus, M. N. G., Andonotopo, W., Bachnas, M. A., Prabowo, W., Yuliantara, E. E., Pramono, M. B. A., Dewantiningrum, J., et al. (2026) · Philippine Journal of Obstetrics and Gynecology · doi:10.4103/pjog.pjog_47_25
Yamashita, A., Kaku, M., Matsunaga, M., Inoue, S., Arizono, K., Ideguchi, T., Watanabe, T., Nishida, S., & Nishikawa, T. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112930
Bunak, I. V., Ивановна, С. М., Startseva, N. M., & Hamoeva, Y. A. (2025) · Diabetes Mellitus · doi:10.14341/dm13143
Gómez-Maldonado, A. P., Preciado, L. L. S., Chávez‐Palencia, C., Pérez-Molina, J. J., & Hunot‐Alexander, C. (2026) · Healthcare · doi:10.3390/healthcare14131819
“Recent evidence from Mexico and Latin America also indicates that advanced maternal age, pregestational obesity, and family history of diabetes are among the most important determinants of GDM risk [7–12].”
Khotimah, H., Arista, D. M., Amelia, R., Ratnaningrum, S. D., & Irwanto, Y. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i5.65 · Cited by 1
., B., & ., P. (2026) · International Journal of Science and Healthcare Research · doi:10.52403/ijshr.20260117
Exploring the Immune-Related Senescence biomarkers in Predicting Gestational Diabetes MellitusPreprint
Gan, Y., Mao, J., He, Y., Chen, Z., Fan, B., Shi, Q., & Qi, H. (2024) · Preprints.org · doi:10.20944/preprints202404.0967.v1
Liu, D., Zhao, D., Zhao, F., Shan, L., Gao, X., Mi, Y., & Qu, P. (2026) · Nutrition Journal · doi:10.1186/s12937-026-01306-w · Cited by 1
“Such iron-induced oxidative stress may act through lipid peroxidation and/or DNA damage to subsequently induce abnormal elevation of insulin resistance and impair pancreatic β-cell function, ultimately leading to persistent hyperglycemia and GDM pathogenesis [11, 13].”
Choi, J., Keum, J., Kwak, M., Kim, S. H., Hoh, J. K., Jeon, B., & Park, H.-K. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08491-6
“…significantly increased adipocyte fatty acid-binding protein (FABP) expression during pregnancy, decreased peroxisome proliferator-activated receptor gamma (PPARγ) expression, insulin receptor substrate (IRS-1) dysfunction, and chronic inflammation mediated by insulin receptor phosphorylation [3].”
Zheng, L., Song, X., Wang, H., & Zhou, W. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02170-z
Shamery, H. T. A., & Sait, N. S. (2026) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20262764
Lin, X., Xie, Q., Xu, Y., Shen, L., Lian, J., & Xiao, Q. (2025) · Medicine · doi:10.1097/md.0000000000045108 · Cited by 1
“[7,9,10] Although several studies have explored whether the altered metabolic and inflammatory profiles in GDM might exacerbate ELA-related complications.”
Tofail, T., Shifat, S. K., Sayeed, F., Hasan, M., Amin, U., & Hasanat, M. A. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.07.008
Ahishakiye, E. (2026) · Research Square · doi:10.21203/rs.3.rs-8448492/v1
Fotă, A., & Petca, A. T. (2026) · Biomedicines · doi:10.3390/biomedicines14081846
“Although current guidelines recommend universal screening between 24 and 28 weeks of gestation, there is increasing recognition that the pathophysiological processes underlying GDM begin much earlier in pregnancy, before hyperglycemia reaches diagnostic thresholds [39,40].”
In-Silico analysis of Stress genes association with Gestational diabetes mellitus
Muhammad, I. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-1767960
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.